Parathyroid carcinoma as a challenging diagnosis: Report of three cases

被引:9
作者
Campenni, Alfredo [1 ]
Ruggeri, Rosaria Maddalena [2 ]
Sindoni, Alessandro [1 ]
Giovinazzo, Salvatore [2 ]
Calbo, Letterio [3 ]
Ieni, Antonio
Monaco, Maurizio [4 ]
Tuccari, Giovanni
Benvenga, Salvatore [2 ,5 ]
Baldari, Sergio [1 ]
机构
[1] Univ Messina, Nucl Med Unit, Dept Radiol Sci, Messina, Italy
[2] Univ Messina, Endocrinol Sect, Dept Clin & Expt Med & Pharmacol, Messina, Italy
[3] Univ Messina, Sect Surg, Dept Human Pathol, Messina, Italy
[4] Univ Messina, Cardiovasc & Thorac Dept, Messina, Italy
[5] AOU Policlin G Martino, Program Mol & Clin Endocrinol & Womens Hlth, Messina, Italy
来源
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM | 2012年 / 11卷 / 03期
关键词
AgNOR; Hypercalcemia; Ki-67; Parathyroid carcinoma; Primary hyperparathyroidism; MANAGEMENT; ADENOMAS; CANCER; KI-67; RETINOBLASTOMA; HYPERCALCEMIA; HYPERPLASIAS; PITFALLS; GLANDS;
D O I
10.14310/horm.2002.1367
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Parathyroid carcinoma (PC) is a rare malignancy with an indolent but progressive course. This rare tumour is often difficult to diagnose preoperatively, thus limiting the efficacy of surgery. As long-term survival is largely dependent on the extent of the primary surgical resection, it is of great importance to consider PC in the differential diagnosis of hyperparathyroidism. We herein report three PC patients with different clinical histories who were followed up at our hospital for over a 5-year period, emphasizing the variability in clinical presentation of this rare tumour. Moreover, NORA (Nucleolar Organizer Regions, a standardised silver-stain, marker of proliferation rate) values encountered in these PC patients confirm that AgNOR analysis may be regarded as an additional tool when the pathologist encounters difficulties in defining parathyroid lesions which are not clearly benign.
引用
收藏
页码:368 / 376
页数:9
相关论文
共 33 条
[1]   PROLIFERATIVE ACTIVITY IN PARATHYROID TUMORS AS DETECTED BY KI-67 IMMUNOSTAINING [J].
ABBONA, GC ;
PAPOTTI, M ;
GASPARRI, G ;
BUSSOLATI, G .
HUMAN PATHOLOGY, 1995, 26 (02) :135-138
[2]   HISTOPATHOLOGICAL VARIABLES AND DNA CYTOMETRY IN PARATHYROID CARCINOMA [J].
BONDESON, L ;
SANDELIN, K ;
GRIMELIUS, L .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (08) :820-829
[3]   NUCLEOLAR ORGANIZER REGIONS IN NORMAL, HYPERPLASTIC AND NEOPLASTIC PARATHYROID-GLANDS [J].
BOQUIST, LLV .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1990, 417 (03) :237-241
[4]   Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism [J].
Campenni, Alfredo ;
Ruggeri, Rosaria M. ;
Sindoni, Alessandro ;
Giovinazzo, Salvatore ;
Calbo, Enrico ;
Ieni, Antonio ;
Calbo, Letterio ;
Tuccari, Giovanni ;
Baldari, Sergio ;
Benvenga, Salvatore .
JOURNAL OF BONE AND MINERAL METABOLISM, 2012, 30 (03) :367-372
[5]   Intrathyroidal parathyroid cancer presenting as a left neck mass [J].
Crescenzo, DG ;
Shabahang, M ;
Garvin, D ;
Evans, SRT .
THYROID, 1998, 8 (07) :597-599
[6]  
DeLellis RA, 2017, WHO CLASSIFICATION T, P147
[7]   Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease [J].
Farnebo, F ;
Auer, G ;
Farnebo, LO ;
Teh, BT ;
Twigg, S ;
Aspenblad, U ;
Thompson, NW ;
Grimelius, L ;
Larsson, C ;
Sandelin, K .
WORLD JOURNAL OF SURGERY, 1999, 23 (01) :68-74
[8]   Parathyroid carcinoma: Sixteen new cases and suggestions for correct management [J].
Favia, G ;
Lumachi, F ;
Polistina, F ;
D'Amico, DF .
WORLD JOURNAL OF SURGERY, 1998, 22 (12) :1225-1230
[9]   Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? [J].
Fernandez-Ranvier, Gustavo G. ;
Khanafshar, Elham ;
Jensen, Kristin ;
Zarnegar, Rasa ;
Lee, James ;
Kebebew, Electron ;
Duh, Quan-Yang ;
Clark, Orlo H. .
CANCER, 2007, 110 (02) :255-264
[10]  
Foppiani Luca, 2007, Endocr Pract, V13, P176